FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns a method for making an activated leukocyte composition involving human leukocyte incubation, exposure to hypotonic shock and addition of physiologically acceptable saline in an amount sufficient for the reconstitution of isotonicity, to the leukocytes. The group of inventions also concerns using: the activated leukocyte composition in preparing a drug for wound healing; a wound healing dressing containing the above composition.
EFFECT: group of inventions provides preparing the composition containing a 90 times increase of the leukocyte count as compared to the known state-of-the-art methods.
16 cl, 3 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DENDRITIC CELL GENERATION FROM MONOCYTIC DENDRITIC CELL PRE-CURSORS BY MEANS OF GM-CSF IN ABSENCE OF ADDITIONAL CYTOKINES | 2004 |
|
RU2364625C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC GASTRODUODENITIS AND FUNCTIONAL DYSPEPSIA IN CHILDREN | 2003 |
|
RU2255337C2 |
| METHOD OF NONDIFFERENTIATED CELL PREPARING | 1996 |
|
RU2177996C2 |
| METHOD OF TREATMENT OF PATIENT WITH BACTERIAL INFECTION | 1998 |
|
RU2147238C1 |
| METHOD FOR OBTAINING UNDIFFERENTIATED CELL | 1996 |
|
RU2215539C2 |
| METHOD OF TREATING PATIENTS SUFFERING LUNG CANCER | 2012 |
|
RU2500435C1 |
| METHOD FOR PRODUCING ACTIVATED LEUKOCYTES FOR ADJUVANT ADOPTIVE IMMUNOTHERAPY OF MALIGNANT GROWTHS | 2009 |
|
RU2414915C2 |
| METHOD FOR PREDICTION OF POSTOPERATIVE COMPLICATIONS IN ONCOLOGICAL PATIENTS | 2008 |
|
RU2384297C1 |
| CO-DIFFERENTIATION OF MONOCYTES FROM ALLOGENEIC DONORS | 2013 |
|
RU2668816C2 |
| MONOCYTIC SELF-SPECIFIC CELLS, STIMULATING AUTOTOLERANCE, AND THEIR USE IN PHARMACEUTIAL PREPARATIONS | 2004 |
|
RU2346041C2 |
